iconstar paper   HIV Articles  
Back grey arrow rt.gif
 
 
EHE Goals Unmet - Two-Thirds of New HIV Infections Occur Among MSM - Inequities & Disparities
 
 
  HIV Infection, Diagnosis, Treatment, and Prevention Among Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2010-2019
 
MMWR Weekly Report December 3, 2021
 
CDC analyzed surveillance data to determine trends in estimated new HIV infections and to assess measures of undiagnosed infection and HIV prevention and treatment services including HIV testing, preexposure prophylaxis (PrEP) use, antiretroviral therapy (ART) adherence, and viral suppression, as well as HIV-related stigma.
 
Intensified and innovative efforts to expand access to HIV testing, prevention, and treatment services for MSM, particularly Black MSM, Hispanic/Latino MSM, and younger MSM, are required to decrease health disparities and reduce new HIV infections by 90% to reach EHE goals. Jurisdictions should identify and implement those programs and interventions most responsive to local needs and acceptable to disproportionately affected populations of MSM. All programs should implement a status neutral approach to reduce barriers to prevention, testing, and treatment by breaking down institutional barriers and reducing HIV-related stigma.
 
These findings indicate that new HIV infections among Black MSM and Hispanic/Latino MSM did not decrease during the decade before EHE implementation despite decreases or stable numbers among other MSM subgroups, and new infections increased among MSM aged 25-34 years. Use of many prevention and treatment strategies were less prevalent among Black MSM, Hispanic/Latino MSM, and younger MSM. Longstanding inequities in access to and delivery of needed services among some racial/ethnic and age groups, particularly Black MSM and Hispanic/Latino MSM, have persisted despite focused efforts to prevent HIV in these populations for decades. Efforts to reduce these and other disparities must address their root causes, including systemic racism, stigma, discrimination, homophobia, poverty, homelessness, and unequal access to care and prevention services (1). Further, PrEP was used by only one third of MSM for whom it was likely indicated, well below the EHE target of 50% PrEP coverage.
 

0123221

Achieving the EHE goals to reduce the number of HIV infections by 90% by 2030 will require that at least 95% of infections are diagnosed and 95% of persons with diagnosed HIV infection are virally suppressed (Supplementary Box, https://stacks.cdc.gov/view/cdc/111462); the most recent available data indicate that among MSM, only 85% of HIV infections are diagnosed and 68% of MSM with diagnosed HIV infection are virally suppressed. Approximately 20% of MSM not previously receiving a diagnosis of HIV infection had not been tested for HIV in the past year, which is inconsistent with CDC recommendations that all sexually active MSM be tested at least annually (5). Missed clinical opportunities for testing were common among MSM who had not been tested in the past year. Further, PrEP was used by only one third of MSM for whom it was likely indicated, well below the EHE target of 50% PrEP coverage (Supplementary Box, https://stacks.cdc.gov/view/cdc/111462). Median HIV-related stigma scores were nearly double the national target (6). The persistence of HIV-related stigma might hinder access to testing, prevention, and treatment for MSM, thus potentially undermining progress toward national goals. Together, these findings suggest the need for innovative approaches that can better deliver testing, prevention, and treatment services to MSM.

0123222

Men who have sex with men (MSM) accounted for two thirds of new HIV infections in the United States in 2019 despite representing approximately 2% of the adult population.
 
The estimated number of new HIV infections among MSM was 25,100 in 2010 and 23,100 in 2019.
 
New infections decreased significantly among White MSM but did not decrease among Black or African American (Black) MSM and Hispanic/Latino MSM.
 
During this period, infections significantly decreased from 7,500 to 5,100 among White MSM (p<0.01) but did not decline significantly among Black or African American (Black) MSM (9,000 to 8,900; p = 0.90) and Hispanic/Latino MSM (6,800 to 7,900; p = 0.10). Infections decreased among MSM aged 13-24 years (10,400 to 5,700; p<0.01) and 45-54 years (2,900 to 2,000; p<0.01) but increased among MSM aged 25-34 years (6,700 to 10,000; p<0.01).

0123223

New infections increased among MSM aged 25-34 years.
 
During 2019, approximately 83% of Black MSM and 80% of Hispanic/Latino MSM compared with 90% of White MSM with HIV had received an HIV diagnosis.
 
The lowest percentage of diagnosed infection was among MSM aged 13-24 years (55%).
 
Among MSM with a likely PrEP indication, discussions about PrEP with a provider and PrEP use were lower among Black MSM (47% and 27%, respectively) and Hispanic/Latino MSM (45% and 31%) than among White MSM (59% and 42%).
 
Among MSM with an HIV diagnosis, adherence to ART and viral suppression were lower among Black MSM (48% and 62%, respectively) and Hispanic/Latino MSM (59% and 67%) compared with White MSM (64% and 74%).
 
Experiences of HIV-related stigma among those with an HIV diagnosis were higher among Black MSM (median = 33; scale = 0-100) and Hispanic/Latino MSM (32) compared with White MSM (26). MSM aged 18-24 years had the lowest adherence to ART (45%) and the highest median stigma score (39).
 
Uses of and barriers to prevention and treatment services. CDC examined NHBS data collected in 2017 among MSM who attended venues where the majority of attending men were MSM in 23 U.S. urban areas and did not report a positive HIV test >12 months before the interview. Among these 7,577 MSM, 79% were tested for HIV in the past 12 months (Table 1). Among 1,181 MSM who visited a health care provider but had not tested in the past 12 months, 78% were not offered an HIV test. Neither HIV testing in the past 12 months nor having visited a provider without testing in the past 12 months differed by race/ethnicity. MSM aged 45-54 years and ≥55 years had the lowest percentages of testing in the past 12 months; visiting providers without a test did not differ by age group.
 
Approximately one half (52%) of HIV-negative MSM with likely PrEP indications** reported having discussed PrEP with a health care provider in the past 12 months, and approximately one third (36%) had used PrEP in the past 12 months (Table 2). Discussing and using PrEP were lowest among MSM aged 18-24 years (44% and 27%, respectively) and ≥55 years (46% and 24%), and varied by race/ethnicity (Black MSM [47% and 27%], Hispanic/Latino MSM [45% and 31%], and White MSM [59% and 42%]).
 
Using MMP data collected during June 2018-May 2019 among MSM with diagnosed HIV infection, an estimated 58% were fully ART dose-adherent in the past 30 days (Table 3). Adherence was lowest among MSM aged 18-24 years (45%) and 25-34 years (48%) and Black MSM (48% compared with 64% among White MSM). Overall, 68% of MSM with diagnosed HIV infection were virally suppressed. Black MSM (62%), American Indian or Alaska Native MSM (65%), and MSM aged 25-34 years (65%) had the lowest percentages of viral suppression.
 
The median HIV-related stigma score among MSM with diagnosed HIV infection was 29 on a scale of 0 to 100. MSM aged 18-24 years had the highest median score (39). Black MSM (33) and Hispanic/Latino MSM (32) had higher median scores than did White MSM (26).

0123224

0123225

-------------------------
 
Several innovative and culturally appropriate strategies have successfully reduced barriers to access of services and might help achieve national goals of improving prevention, diagnosis, and treatment of HIV infection among MSM. For example, HIV testing scale-up has been determined to be cost-effective across diverse local conditions (7). Some jurisdictions have successfully implemented programs that increased screening frequency among MSM (8). Numerous strategies have been implemented to deliver HIV testing services to MSM by expanding or tailoring existing clinical screening programs, enhancing community-based testing options, or providing HIV self-tests (9). HIV self-testing can be a cost-saving delivery strategy (10) with potential to mitigate HIV-related stigma and better reach MSM (11). Multiple jurisdictions have demonstrated that HIV self-test distribution programs can successfully deliver HIV testing to racial/ethnic minority MSM and MSM not reached by other testing programs (12). CDC recently supported a national self-test distribution program designed to improve access to HIV testing for those who had not been previously reached.
 
To improve HIV care outcomes, strategies and approaches supported by the Ryan White HIV/AIDS Program (RWHAP) can be scaled up to reach all U.S. facilities that provide HIV care. RWHAP-funded facilities deliver comprehensive care and essential support services to approximately one half of persons with diagnosed HIV infection in the United States through enhanced collaboration with local partners, community engagement, effective data collection, and provider training. RWHAP activities have led to recent increases in viral suppression among MSM from 84.7% in 2015 to 89.1% in 2019 (13). These activities also reduced racial/ethnic disparities by as much as one third by addressing structural factors, such as unstable housing, that impede access to HIV care and treatment (14). Other programs have used surveillance data to identify persons not receiving care and have successfully engaged them using interventions such as patient navigation to reduce barriers to access (15).
 
Prevention of new infections can be enhanced by ensuring that PrEP providers are available in communities most affected by HIV and by integrating PrEP services into existing clinical settings, such as sexually transmitted disease (STD) clinics. As part of the EHE initiative, CDC supports local efforts to build the capacity of STD clinics to implement innovative, locally tailored strategies to provide PrEP and other HIV prevention services to MSM at risk for acquiring HIV.*** Such clinics often function as safety nets for populations with limited access to other sources of care, thus providing crucial prevention services to underserved populations and reducing racial/ethnic disparities in care (16). Local programs have highlighted opportunities to improve rapid PrEP initiation and navigation services for STD clinic patients with ongoing risk for HIV infection (17).
 
Emerging interventions and delivery strategies for testing, prevention, and treatment might also reduce barriers to accessing services and reaching EHE goals. Telehealth and other novel care models can provide additional options for accessing and improving adherence to HIV treatment and PrEP (18,19). Development of long-acting HIV medications could further expand access and facilitate adherence to PrEP and ART (20). Such innovative interventions and delivery strategies should be prioritized for use among the most disproportionately affected groups, including Black and Hispanic/Latino MSM and younger MSM. Their implementation should be designed to address structural factors that often limit access to and use of these technologies. To further promote engagement in HIV services and reduce HIV-related stigma, MSM should be engaged in HIV prevention or treatment services regardless of their HIV status (i.e., a status neutral approach) (1). This approach helps persons with HIV and persons at higher risk for infection receive the services needed to prevent HIV transmission or acquisition without status-specific structures that reinforce stigma and other related barriers.
 
The findings in this report are subject to at least seven limitations. First, data were collected before the onset of the COVID-19 pandemic and do not reflect disruptions in HIV testing, prevention, or treatment services. Second, MMP and NHBS data were self-reported and are subject to recall and social desirability biases. Third, NHBS behavioral measures of likely PrEP indication did not correspond directly with clinical guidelines and might have underestimated MSM with likely PrEP indications who discussed PrEP with a health care provider or used PrEP. Fourth, viral suppression measures presented here did not include data from jurisdictions without complete laboratory reporting and therefore might not be representative of all persons with diagnosed HIV infection in the United States. Fifth, the small number of MSM in some subgroups might have reduced the reliability of their estimates. Sixth, outcomes based on NHSS data for MSM aged 13-24 years were presented for a single age category, potentially obscuring differences in this developmentally diverse group. Finally, NHSS data presented by transmission category (i.e., male-to-male sexual contact) are based on sex at birth. Therefore, estimates based on NHSS data included some persons with a gender identity other than male (e.g., transgender women) who were classified as MSM based on their sex at birth.
 
Intensified and innovative efforts to expand access to HIV testing, prevention, and treatment services for MSM, particularly Black MSM, Hispanic/Latino MSM, and younger MSM, are required to decrease health disparities and reduce new HIV infections by 90% to reach EHE goals. Jurisdictions should identify and implement those programs and interventions most responsive to local needs and acceptable to disproportionately affected populations of MSM. All programs should implement a status neutral approach to reduce barriers to prevention, testing, and treatment by breaking down institutional barriers and reducing HIV-related stigma.

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org